PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fusion Public Relations, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Microsoft Research Sponsors BioMed Central 2007 Research Awards - BioMed Central, the world’s largest publisher of peer-reviewed, open access research journals, is pleased to announce that Microsoft Research has agreed to be the premium sponsor of the BioMed Central Research Awards for 2007 - BioMedCentral.com
Microsoft Research Sponsors BioMed Central 2007 Research Awards

 

NewswireToday - /newswire/ - Bray Maidenhead, Berkshire, United Kingdom, 2007/09/05 - BioMed Central, the world’s largest publisher of peer-reviewed, open access research journals, is pleased to announce that Microsoft Research has agreed to be the premium sponsor of the BioMed Central Research Awards for 2007 - BioMedCentral.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The BioMed Central Research Awards, which began accepting nominations in late July, recognize excellence in research that has been made universally accessible by open access publication in one of the publisher’s 180 journals.

“Microsoft’s External Research group is proud to be a sponsor of the BioMed Central Research Awards and feel it is important to recognize excellence in research,” said Lee Dirks, director, scholarly communications, Microsoft Research. “We are very supportive of the open science movement and recognize that open access publication is an important component of overall scholarly communications.”

Nominations for the awards are now being accepted and will close December 21, 2007. Anyone who publishes original research of major significance in one of BioMed Central’s journals during 2007 is eligible for nomination. Two awards of $5000 (US) will be made — one for biology research, and one for medical research. The winning articles will be selected by a panel including BioMed Central editorial team members and external experts in biology and medicine. Winners will be announced at the BioMed Central Research Awards dinner in early March 2008.

“We’re very pleased that Microsoft Research has shown its commitment to advancing open science by supporting this year’s BioMed Central Research Awards,” said Dr. Matthew Cockerill, BioMed Central's publisher. “With these awards, BioMed Central aims to encourage and reward authors who select BioMed Central journals to publish their very best research.”

The first BioMed Central Research Awards were a great success. The winners were announced at the BioMed Central Open Access Colloquium in February 2007, at the Royal College of Physicians, London.

“Winning a BioMed Central Research Award last year has been a tremendous help with my research,” said Dr. Flavio Zolessi, Professor Adjunto, Universidad de la Republica, Uruguay. “I used the award to purchase equipment and reagents needed for establishing, for the first time in Uruguay, a research line about zebrafish development. Additionally, I have been invited to speak in Uruguay and around South America. This was in due in part to the fact that the paper was published in a very promising open access journal.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fusion Public Relations, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Microsoft Research Sponsors BioMed Central 2007 Research Awards

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sarah Bedwell - FusionPR.com 
+44(0)16 2850 2601 sarah[.]fusionpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fusion Public Relations, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fusion Public Relations, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)